BP Castrol Sanofi vaccine Deal Highlights Major Pharma and
The BP Castrol Sanofi vaccine deal illustrates Sanofi’s focus on expanding its role in global immunization while BP shifts away from non-core assets like
Sanofi Dren Bio deal: $1.8B collaboration in immune medicine
The Sanofi Dren Bio deal involves Sanofi's acquisition of Dren Bio in a potential $1.8 billion investment to expand its immunology portfolio and develop